U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H17Br2NO2
Molecular Weight 379.088
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEMBREXINE

SMILES

O[C@H]1CC[C@@H](CC1)NCC2=C(O)C(Br)=CC(Br)=C2

InChI

InChIKey=GEDPQKGMHLHFOZ-XYPYZODXSA-N
InChI=1S/C13H17Br2NO2/c14-9-5-8(13(18)12(15)6-9)7-16-10-1-3-11(17)4-2-10/h5-6,10-11,16-18H,1-4,7H2/t10-,11-

HIDE SMILES / InChI

Molecular Formula C13H17Br2NO2
Molecular Weight 379.088
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/3363832 | http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500013623.pdf

Dembrexine is a mucolytic agent which reduces the viscosity of respiratory mucus. It improves movement of mucus in small airways. Dembrexine increases secretion of the serous cells in the glands of the nasal, tracheal and bronchial cells and in type II alveolar cells. It also possesses an anti-tussive effect. Dembrexine is used in the treatment of respiratory disease in horses. All respiratory infections with increased secretions. Acute, sub-acute bronchitis. Chronic respiratory disease. Infection of the upper airways.

Originator

Curator's Comment: # Boehringer Ingelheim Gmbh

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Sputolosin

Approved Use

The drug is indicated for the treatment of respiratory disease in horses. All respiratory infections with increased secretions. Acute, sub-acute bronchitis. Chronic respiratory disease. Infection of the upper airways.
Palliative
Sputolosin

Approved Use

The drug is indicated for the treatment of respiratory disease in horses. All respiratory infections with increased secretions. Acute, sub-acute bronchitis. Chronic respiratory disease. Infection of the upper airways.
Palliative
Sputolosin

Approved Use

The drug is indicated for the treatment of respiratory disease in horses. All respiratory infections with increased secretions. Acute, sub-acute bronchitis. Chronic respiratory disease. Infection of the upper airways.
Palliative
Sputolosin

Approved Use

The agent is indicated for the treatment of foal pneumonia.
PubMed

PubMed

TitleDatePubMed
The trans-cis isomerization of trans-4'-(2-hydroxy-3,5-dibromo-benzylamino)cyclohexanol in vivo and in vitro in different species.
1986 Jul
The mucolytic effect of Sputolosin in horses with respiratory disease.
1988 Jan 30
Patents

Sample Use Guides

Twice daily administration of 0.3 mg active ingredient per kg bodyweight. Adult horses (500 kg): 30 g powder twice daily in the food. Small horses, ponies and foals: 10 g powder per 170 kg bodyweight twice daily.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:18:14 GMT 2023
Edited
by admin
on Fri Dec 15 16:18:14 GMT 2023
Record UNII
4F61F502T5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEMBREXINE
INN   MART.  
INN  
Official Name English
DEMBROXOL
Common Name English
SPUTOLOSIN
Brand Name English
TRANS-4-((3,5-DIBROMOSALICYL)AMINO)CYCLOHEXANOL
Systematic Name English
DEMBREXINE [MART.]
Common Name English
dembrexine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C74536
Created by admin on Fri Dec 15 16:18:14 GMT 2023 , Edited by admin on Fri Dec 15 16:18:14 GMT 2023
Code System Code Type Description
FDA UNII
4F61F502T5
Created by admin on Fri Dec 15 16:18:14 GMT 2023 , Edited by admin on Fri Dec 15 16:18:14 GMT 2023
PRIMARY
EVMPD
SUB06961MIG
Created by admin on Fri Dec 15 16:18:14 GMT 2023 , Edited by admin on Fri Dec 15 16:18:14 GMT 2023
PRIMARY
EPA CompTox
DTXSID30101639
Created by admin on Fri Dec 15 16:18:14 GMT 2023 , Edited by admin on Fri Dec 15 16:18:14 GMT 2023
PRIMARY
SMS_ID
100000083709
Created by admin on Fri Dec 15 16:18:14 GMT 2023 , Edited by admin on Fri Dec 15 16:18:14 GMT 2023
PRIMARY
NCI_THESAURUS
C78114
Created by admin on Fri Dec 15 16:18:14 GMT 2023 , Edited by admin on Fri Dec 15 16:18:14 GMT 2023
PRIMARY
INN
5315
Created by admin on Fri Dec 15 16:18:14 GMT 2023 , Edited by admin on Fri Dec 15 16:18:14 GMT 2023
PRIMARY
CAS
83200-09-3
Created by admin on Fri Dec 15 16:18:14 GMT 2023 , Edited by admin on Fri Dec 15 16:18:14 GMT 2023
PRIMARY
ChEMBL
CHEMBL2106163
Created by admin on Fri Dec 15 16:18:14 GMT 2023 , Edited by admin on Fri Dec 15 16:18:14 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY